{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-013295","form_type":"8-K","ticker":"TOI","cik":"0001799191","company_name":"Oncology Institute, Inc.","filed_at":"2024-03-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.570981+00:00","generated_at":"2026-06-04T07:19:08.652275+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"medium","headline":"TOI reports Q4 revenue $86M (+20.1% YoY), net loss widens to $18.8M","bullets":["Q4 2023 revenue $86M (+20.1% YoY); gross profit $14M (-8.0% YoY).","Net loss $18.8M (vs $11.0M loss in Q4 2022); diluted EPS -$0.21.","Adjusted EBITDA -$6.3M (vs -$4.6M in prior year quarter).","Operational: remediated material weakness, signed full-risk contract in South Florida, launched CA pharmacy with 1,300 specialty fills.","Ended 2023 with 69 clinics, 119 providers; cash $83M. 2024 outlook mentioned but not detailed."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-013295","json":"https://secwatch.observer/filing/0001628280-24-013295.json","markdown":"https://secwatch.observer/filing/0001628280-24-013295.md","text":"https://secwatch.observer/filing/0001628280-24-013295.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799191/000162828024013295/0001628280-24-013295-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799191/000162828024013295/toi-20240327.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T07:19:08.652275+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"cb57ef3510090621ab448698ae1fd8cf64adba84","claim":"Oncology Institute, Inc. reported fourth quarter and fiscal year ended December 31, 2023 results: revenue $86 million, net income $18.8 million, EPS $(0.21).","evidence_excerpt":"Officer. • Hired 7 new providers in the quarter and ended the year with 69 clinics and 119 employed providers. Fourth Quarter 2023 Financial Highlights • Consolidated revenue of $86 million, an increase of 20.1% compared to the prior year quarter • Gross profit of $14 million, a decrease of 8.0% compared to the prior year quarter • Net loss of $18.8 million compared","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799191/000162828024013295/0001628280-24-013295-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fourth quarter and fiscal year ended December 31, 2023"},{"label":"Revenue","value":"$86 million"},{"label":"Net income","value":"$18.8 million"},{"label":"EPS","value":"$(0.21)"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}